Table 6.
Personal interpretation of therapeutic options according to liver disease.
| Liver disease | Contraindication to Peg-IFN | Standard therapy |
|---|---|---|
| Chronic hepatitis or compensated cirrhosis without esophageal varices | no | Peg-IFN+Bulevirtide 2mg for 48 weeks |
| yes | Bulevirtide 2mg | |
| Compensated cirrhosis with esophageal varices | Yes | Bulevirtide 2mg |
| Decompensated cirrhosis | yes | Unknown Bulevirtide 2 mg is an option |